2 results
Approved WMOPending
To identify possible in vivo biochemical and biological markers related to aneurysm wall strength.
Approved WMORecruiting
The objective of this prospective, randomized study is to investigate the efficacy and safety of HSCT compared to the comparator group (alemtuzumab, cladribine or ocrelizumab) in patients with aggressive relapsing remitting MS. In Norway, theā¦